Elizabeth Blume

Publications

1. From worries to resilience: a qualitative study of the psychosocial experiences of diverse adolescents and young adults with heart failure and their caregivers. Cardiol Young. 2024 Oct 21; 1-8. View Abstract
2. Teaching pediatric cardiology fellows to communicate serious news: a pilot study. BMC Med Educ. 2024 Oct 07; 24(1):1092. View Abstract
3. Socioeconomic Status and Major Adverse Transplant Events in Pediatric Heart Transplant Recipients. JAMA Netw Open. 2024 Oct 01; 7(10):e2437255. View Abstract
4. Pathology of explanted pediatric hearts: An 11-year study. Population characteristics and implications for outcomes. Pediatr Transplant. 2024 Jun; 28(4):e14742. View Abstract
5. The experience of fathers of children hospitalised with advanced heart disease. Cardiol Young. 2024 Jun; 34(6):1274-1278. View Abstract
6. The Conduit to Improving Outcomes: Supporting the Vulnerable Myocardium in Hypoplastic Left Heart Syndrome. JACC Adv. 2024 Feb; 3(2):100809. View Abstract
7. The family burden of paediatric heart disease during the chronic phase of illness. Cardiol Young. 2024 May; 34(5):997-1003. View Abstract
8. Medium-term Outcomes in Pediatric Heart Transplant Recipients Managed Using a Steroid Avoidance Immune Suppression Protocol. Transplantation. 2024 Jan 01; 108(1):e8-e14. View Abstract
9. The roles of preparation, location, and palliative care involvement in parent-perceived child suffering at the end of life. J Pediatr Nurs. 2023 Sep-Oct; 72:e166-e173. View Abstract
10. The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update. J Heart Lung Transplant. 2023 07; 42(7):e1-e222. View Abstract
11. Medical and End-of-Life Decision-Making Preferences in Adolescents and Young Adults with Advanced Heart Disease and Their Parents. JAMA Netw Open. 2023 05 01; 6(5):e2311957. View Abstract
12. Apixaban Anticoagulation in Children and Young Adults Supported With the HeartMate 3 Ventricular Assist Device. ASAIO J. 2023 06 01; 69(6):e267-e269. View Abstract
13. Patient and parent-reported outcomes in paediatric ventricular assist device support: a multi-center ACTION learning network feasibility and pilot experience. Cardiol Young. 2023 Nov; 33(11):2258-2266. View Abstract
14. Palliative Care Across the Life Span for Children With Heart Disease: A Scientific Statement From the American Heart Association. Circ Cardiovasc Qual Outcomes. 2023 02; 16(2):e000114. View Abstract
15. Finding the Words and Data to Discuss Donor Characteristics With Heart Transplant Recipients and Families: Reconsidering Risk. JAMA Cardiol. 2022 11 01; 7(11):1127-1128. View Abstract
16. Prognostic Value of Exercise Stress Echocardiography in Pediatric Cardiac Transplant Recipients. J Am Soc Echocardiogr. 2022 11; 35(11):1133-1138.e2. View Abstract
17. Parent-Provider Communication in Hospitalized Children with Advanced Heart Disease. Pediatr Cardiol. 2022 Dec; 43(8):1761-1769. View Abstract
18. The Surprise Question as a Trigger for Primary Palliative Care Interventions for Children with Advanced Heart Disease. Pediatr Cardiol. 2022 Dec; 43(8):1822-1831. View Abstract
19. Assessment of an Instrument to Measure Interdisciplinary Staff Perceptions of Quality of Dying and Death in a Pediatric Cardiac Intensive Care Unit. JAMA Netw Open. 2022 05 02; 5(5):e2210762. View Abstract
20. Pediatric heart transplant waiting times in the United States since the 2016 allocation policy change. Am J Transplant. 2022 03; 22(3):833-842. View Abstract
21. Obesity and dyslipidemia predict cardiac allograft vasculopathy and graft loss in children and adolescents post-heart transplant: A PHTS multi-institutional analysis. Pediatr Transplant. 2022 08; 26(5):e14244. View Abstract
22. Self-reported quality of life in children with ventricular assist devices. Pediatr Transplant. 2022 06; 26(4):e14237. View Abstract
23. Design and pilot testing of therapeutic clothing for hospitalized children. J Spec Pediatr Nurs. 2022 04; 27(2):e12363. View Abstract
24. A "Good Death" for Children with Cardiac Disease. Pediatr Cardiol. 2022 Apr; 43(4):744-755. View Abstract
25. Circumstances surrounding end-of-life in pediatric patients pre- and post-heart transplant: a report from the Pediatric Heart Transplant Society. Pediatr Transplant. 2022 Mar; 26(2):e14196. View Abstract
26. Native Bicuspid Pulmonary Valve in D-Loop Transposition of the Great Arteries: Outcomes of the Neo-Aortic Valve Function and Root Dilation After Arterial Switch Operation. J Am Heart Assoc. 2021 09 21; 10(18):e021599. View Abstract
27. Parent-Reported Symptoms and Perceived Effectiveness of Treatment in Children Hospitalized with Advanced Heart Disease. J Pediatr. 2021 Nov; 238:221-227.e1. View Abstract
28. State of the science and future research directions in palliative and end-of-life care in paediatric cardiology: a report from the Harvard Radcliffe Accelerator Workshop. Cardiol Young. 2022 Mar; 32(3):431-436. View Abstract
29. ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart Association. J Heart Lung Transplant. 2021 08; 40(8):709-732. View Abstract
30. Burnout, professional fulfillment, and post-traumatic stress among pediatric solid organ transplant teams. Pediatr Transplant. 2021 Jun; 25(4):e14020. View Abstract
31. Palliative Care Referrals in Cardiac Disease. Pediatrics. 2021 03; 147(3). View Abstract
32. Parent and Physician Understanding of Prognosis in Hospitalized Children With Advanced Heart Disease. J Am Heart Assoc. 2021 01 19; 10(2):e018488. View Abstract
33. Variability in clinical decision-making for ventricular assist device implantation in pediatrics. Pediatr Transplant. 2020 12; 24(8):e13840. View Abstract
34. Fourth Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report. Ann Thorac Surg. 2020 12; 110(6):1819-1831. View Abstract
35. Comparison of tissue Doppler imaging and conventional echocardiography to discriminate rejection from non-rejection after pediatric heart transplantation. Pediatr Transplant. 2020 08; 24(5):e13738. View Abstract
36. The re-occurrence of cardiomyopathy in propionic acidemia after liver transplantation. JIMD Rep. 2020 Jul; 54(1):3-8. View Abstract
37. Extracorporeal Membrane Oxygenation Support After Heart Transplantation in Children-Outcomes of a Single Center Cohort. Pediatr Crit Care Med. 2020 04; 21(4):332-339. View Abstract
38. Three-Dimensional Speckle Tracking Echocardiography for Assessment of Left Ventricular Function and Myocardial Mechanics after Pediatric Heart Transplantation. J Heart Lung Transplant. 2020 Apr; 39(4S):S457. View Abstract
39. "How are You Doing?": Patient and Family Support Resources for Children on Ventricular Assist Device. J Heart Lung Transplant. 2020 Apr; 39(4S):S465. View Abstract
40. Obesity Leads to Increased Mortality in Pediatric Heart Transplant Recipients - A Pediatric Heart Transplant Society Study. J Heart Lung Transplant. 2020 Apr; 39(4S):S85-S86. View Abstract
41. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Transplantation. 2020 01; 104(1):e31-e37. View Abstract
42. Fears and Stressors of Trainees Starting Fellowship in Pediatric Cardiology. Pediatr Cardiol. 2020 Apr; 41(4):677-682. View Abstract
43. Medical and end-of-life decision making in adolescents' pre-heart transplant: A descriptive pilot study. Palliat Med. 2020 03; 34(3):272-280. View Abstract
44. Congenital Cardiothoracic Surgeons and Palliative Care: A National Survey Study. J Palliat Care. 2021 Jan; 36(1):17-21. View Abstract
45. Integration of Pediatric Palliative Care Into Cardiac Intensive Care: A Champion-Based Model. Pediatrics. 2019 08; 144(2). View Abstract
46. Phenotypic Manifestations of Arrhythmogenic Cardiomyopathy in Children and Adolescents. J Am Coll Cardiol. 2019 07 23; 74(3):346-358. View Abstract
47. Is Doppler echocardiography useful for estimating left ventricular filling pressures in pediatric heart transplant recipients? Pediatr Transplant. 2019 11; 23(7):e13543. View Abstract
48. Early outcomes for low-risk pediatric heart transplant recipients and steroid avoidance: A multicenter cohort study (Clinical Trials in Organ Transplantation in Children - CTOTC-04). J Heart Lung Transplant. 2019 09; 38(9):972-981. View Abstract
49. Palliative care and paediatric cardiology: current evidence and future directions. Lancet Child Adolesc Health. 2019 07; 3(7):502-510. View Abstract
50. Third Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report: Preimplant Characteristics and Outcomes. Ann Thorac Surg. 2019 04; 107(4):993-1004. View Abstract
51. Compassionate deactivation of ventricular assist devices in children: A survey of pediatric ventricular assist device clinicians' perspectives and practices. Pediatr Transplant. 2019 05; 23(3):e13359. View Abstract
52. When a Child Needs a Transplant but Lacks Familial Social Support. Pediatrics. 2019 01; 143(1). View Abstract
53. Ventricular Assist Device Support as a Bridge to Transplantation in Pediatric Patients. J Am Coll Cardiol. 2018 07 24; 72(4):402-415. View Abstract
54. Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC-04 multi-institutional study. Am J Transplant. 2018 09; 18(9):2148-2162. View Abstract
55. Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC-04 study. Am J Transplant. 2018 09; 18(9):2163-2174. View Abstract
56. Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children-04 (CTOTC-04) in pediatric heart transplantation. Am J Transplant. 2018 09; 18(9):2135-2147. View Abstract
57. Physician Perspectives on Palliative Care for Children with Advanced Heart Disease: A Comparison between Pediatric Cardiology and Palliative Care Physicians. J Palliat Med. 2018 06; 21(6):773-779. View Abstract
58. Post-transplant outcomes in pediatric ventricular assist device patients: A PediMACS-Pediatric Heart Transplant Study linkage analysis. J Heart Lung Transplant. 2018 06; 37(6):715-722. View Abstract
59. Liver abnormalities and post-transplant survival in pediatric Fontan patients. Pediatr Transplant. 2017 Dec; 21(8). View Abstract
60. Homozygous EEF1A2 mutation causes dilated cardiomyopathy, failure to thrive, global developmental delay, epilepsy and early death. Hum Mol Genet. 2017 09 15; 26(18):3545-3552. View Abstract
61. Patterns and Outcomes of Care in Children With Advanced Heart Disease Receiving Palliative Care Consultation. J Pain Symptom Manage. 2018 02; 55(2):351-358. View Abstract
62. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017 Oct; 36(10):1080-1086. View Abstract
63. Second annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) report: Pre-implant characteristics and outcomes. J Heart Lung Transplant. 2018 01; 37(1):38-45. View Abstract
64. Pediatric Cardiology Provider Attitudes About Palliative Care: A Multicenter Survey Study. Pediatr Cardiol. 2017 Oct; 38(7):1324-1331. View Abstract
65. The Evolution of a Pediatric Ventricular Assist Device Program: The Boston Children's Hospital Experience. Pediatr Cardiol. 2017 Jun; 38(5):1032-1041. View Abstract
66. Deactivation of Ventricular Assist Devices: Perspectives and Experiences of Adult Cardiovascular Providers. J Card Fail. 2017 06; 23(6):485-486. View Abstract
67. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: An analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). J Heart Lung Transplant. 2018 01; 37(1):89-99. View Abstract
68. Trans-Fontan baffle placement of an endocardial systemic ventricular pacing lead. HeartRhythm Case Rep. 2017 Feb; 3(2):129-132. View Abstract
69. Does Small Size Matter With Continuous Flow Devices?: Analysis of the INTERMACS Database of Adults With BSA =1.5 m2. JACC Heart Fail. 2017 02; 5(2):123-131. View Abstract
70. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients. J Heart Lung Transplant. 2017 Apr; 36(4):434-442. View Abstract
71. Palliative Care for Patients With End-Stage Cardiovascular Disease and Devices: A Report From the Palliative Care Working Group of the Geriatrics Section of the American College of Cardiology. JAMA Intern Med. 2016 07 01; 176(7):1017-9. View Abstract
72. Is Endomyocardial Biopsy a Safe and Useful Procedure in Children with Suspected Cardiomyopathy? Pediatr Cardiol. 2016 Oct; 37(7):1200-10. View Abstract
73. Report of the National Heart, Lung, and Blood Institute Working Group: An Integrated Network for Congenital Heart Disease Research. Circulation. 2016 Apr 05; 133(14):1410-8. View Abstract
74. Adverse events in children implanted with ventricular assist devices in the United States: Data from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant. 2016 05; 35(5):569-77. View Abstract
75. Outcomes of children implanted with ventricular assist devices in the United States: First analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant. 2016 05; 35(5):578-84. View Abstract
76. Outcomes of pediatric patients supported with continuous-flow ventricular assist devices: A report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant. 2016 05; 35(5):585-90. View Abstract
77. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? Circ Heart Fail. 2016 Jan; 9(1):e002328. View Abstract
78. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015 Dec; 34(12):1495-504. View Abstract
79. Pediatric mechanical circulatory support: available devices and outcomes as bridge-to-transplant therapy. Curr Opin Organ Transplant. 2015 Oct; 20(5):557-61. View Abstract
80. Physician and parent perceptions of prognosis and end-of-life experience in children with advanced heart disease. J Palliat Med. 2015 Apr; 18(4):318-23. View Abstract
81. Adrenergic receptor genotype influences heart failure severity and ß-blocker response in children with dilated cardiomyopathy. Pediatr Res. 2015 Feb; 77(2):363-9. View Abstract
82. Association of hemodynamic profiles with wait-list mortality in children listed for heart transplantation with idiopathic dilated cardiomyopathy. Am J Cardiol. 2015 Jan 15; 115(2):243-8. View Abstract
83. Treatment and outcomes of immune cytopenias following solid organ transplant in children. Pediatr Blood Cancer. 2015 02; 62(2):214-218. View Abstract
84. Parental perspectives on suffering and quality of life at end-of-life in children with advanced heart disease: an exploratory study*. Pediatr Crit Care Med. 2014 May; 15(4):336-42. View Abstract
85. Risk factors and outcome of Fontan-associated plastic bronchitis: a case-control study. J Am Heart Assoc. 2014 Apr 22; 3(2):e000865. View Abstract
86. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant. 2014 Jun; 33(6):555-64. View Abstract
87. Ventricular assist devices in children: progress with an orphan device application. Circulation. 2014 Apr 08; 129(14):1530-7. View Abstract
88. Survival in patients removed from the heart transplant waiting list before receiving a transplant. J Heart Lung Transplant. 2014 Mar; 33(3):261-9. View Abstract
89. Tissue Doppler imaging for rejection surveillance in pediatric heart transplant recipients. J Heart Lung Transplant. 2013 Oct; 32(10):1027-33. View Abstract
90. Antibody depletion for the treatment of crossmatch-positive pediatric heart transplant recipients. Pediatr Transplant. 2013 Nov; 17(7):661-9. View Abstract
91. Prognostic value of exercise testing during heart transplant evaluation in children. Circ Heart Fail. 2013 Jul; 6(4):792-9. View Abstract
92. Ten yr of pediatric heart transplantation: a report from the Pediatric Heart Transplant Study. Pediatr Transplant. 2013 Mar; 17(2):99-111. View Abstract
93. Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation. 2013 Jan 22; 127(3):331-9. View Abstract
94. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. J Heart Lung Transplant. 2012 Dec; 31(12):1241-52. View Abstract
95. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. Circ Heart Fail. 2013 Jan; 6(1):145-50. View Abstract
96. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Circ Heart Fail. 2013 Jan; 6(1):e1-e11. View Abstract
97. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. Ann Thorac Surg. 2012 Dec; 94(6):e163-8. View Abstract
98. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Ann Thorac Surg. 2012 Dec; 94(6):2147-58. View Abstract
99. Cardiac allograft function during the first year after transplantation in rejection-free children and young adults. Circ Cardiovasc Imaging. 2012 Nov; 5(6):756-64. View Abstract
100. Allograft-Transmitted Histoplasma capsulatum Infection in a Solid Organ Transplant Recipient. J Pediatric Infect Dis Soc. 2013 Sep; 2(3):270-3. View Abstract
101. Patterns of care at end of life in children with advanced heart disease. Arch Pediatr Adolesc Med. 2012 Aug; 166(8):745-8. View Abstract
102. Utility of exercise stress echocardiography in pediatric cardiac transplant recipients: a single-center experience. J Heart Lung Transplant. 2012 May; 31(5):517-23. View Abstract
103. Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. J Heart Lung Transplant. 2012 Apr; 31(4):398-409. View Abstract
104. Comparison of risk factors and outcomes for pediatric patients listed for heart transplantation after bidirectional Glenn and after Fontan: an analysis from the Pediatric Heart Transplant Study. J Heart Lung Transplant. 2012 Feb; 31(2):133-9. View Abstract
105. Sudden death after pediatric heart transplantation: analysis of data from the Pediatric Heart Transplant Study Group. J Heart Lung Transplant. 2011 Dec; 30(12):1395-402. View Abstract
106. Berlin Heart EXCOR Pediatric ventricular assist device Investigational Device Exemption study: study design and rationale. Am Heart J. 2011 Sep; 162(3):425-35.e6. View Abstract
107. Association of graft ischemic time with survival after heart transplant among children in the United States. J Heart Lung Transplant. 2011 Nov; 30(11):1244-9. View Abstract
108. Outcomes after listing for primary transplantation for infants with unoperated-on non-hypoplastic left heart syndrome congenital heart disease: a multi-institutional study. J Heart Lung Transplant. 2011 Sep; 30(9):1023-32. View Abstract
109. The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy. J Heart Lung Transplant. 2011 Jul; 30(7):755-60. View Abstract
110. Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT. Bone Marrow Transplant. 2011 Dec; 46(12):1532-9. View Abstract
111. Patterns of End-of-Life Care in Children with Advanced Heart Disease (747). J Pain Symptom Manage. 2011 Jan; 41(1):301. View Abstract
112. Infection and malignancy after pediatric heart transplantation: the role of induction therapy. J Heart Lung Transplant. 2011 Mar; 30(3):299-308. View Abstract
113. Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: a multi-institutional study. J Heart Lung Transplant. 2011 Mar; 30(3):282-8. View Abstract
114. Minimizing infection and rejection death: clues acquired from 19 years of multi-institutional cardiac transplantation data. J Heart Lung Transplant. 2011 Feb; 30(2):151-7. View Abstract
115. Association of race and socioeconomic position with outcomes in pediatric heart transplant recipients. Am J Transplant. 2010 Sep; 10(9):2116-23. View Abstract
116. Outcomes of heart transplantation using donor hearts from infants with sudden infant death syndrome. J Heart Lung Transplant. 2010 Nov; 29(11):1226-30. View Abstract
117. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial. Circ Heart Fail. 2010 Sep; 3(5):606-11. View Abstract
118. Impact of ABO-incompatible listing on wait-list outcomes among infants listed for heart transplantation in the United States: a propensity analysis. Circulation. 2010 May 04; 121(17):1926-33. View Abstract
119. Decline in rejection in the first year after pediatric cardiac transplantation: a multi-institutional study. J Heart Lung Transplant. 2010 Jun; 29(6):625-32. View Abstract
120. Use of a virtual community as a psychosocial support system in pediatric transplantation. Pediatr Transplant. 2010 Mar; 14(2):261-7. View Abstract
121. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients. J Heart Lung Transplant. 2010 May; 29(5):517-22. View Abstract
122. Racial and ethnic differences in mortality in children awaiting heart transplant in the United States. Am J Transplant. 2009 Dec; 9(12):2808-15. View Abstract
123. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant. 2009 Dec; 28(12):1292-8. View Abstract
124. Evaluating failing Fontans for heart transplantation: predictors of death. Ann Thorac Surg. 2009 Aug; 88(2):558-63; discussion 563-4. View Abstract
125. Socioeconomic position and graft failure in pediatric heart transplant recipients. Circ Heart Fail. 2009 May; 2(3):160-5. View Abstract
126. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009 Feb 10; 119(5):717-727. View Abstract
127. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant. 2009 Jan; 28(1):44-50. View Abstract
128. The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood. Pediatr Cardiol. 2009 Apr; 30(3):306-10. View Abstract
129. Ventricular assist devices as a bridge to heart transplantation in children. J Cardiovasc Nurs. 2008 Jan-Feb; 23(1):25-9. View Abstract
130. Intra-aortic balloon pump use in the failing Fontan circulation. Congenit Heart Dis. 2008 Jan-Feb; 3(1):60-2. View Abstract
131. Longitudinal changes in heart rate recovery after maximal exercise in pediatric heart transplant recipients: evidence of autonomic re-innervation? J Heart Lung Transplant. 2007 Dec; 26(12):1306-12. View Abstract
132. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007 Sep 12; 298(10):1171-9. View Abstract
133. Outcome after Fontan failure and takedown to an intermediate palliative circulation. Ann Thorac Surg. 2007 Sep; 84(3):880-7. View Abstract
134. Parenting stress and parental post-traumatic stress disorder in families after pediatric heart transplantation. J Heart Lung Transplant. 2007 Feb; 26(2):120-6. View Abstract
135. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007 Feb 06; 115(5):658-76. View Abstract
136. Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia. J Heart Lung Transplant. 2006 Nov; 25(11):1376-9. View Abstract
137. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006 Jul 25; 114(4):273-80. View Abstract
138. Successful implantation of a Berlin heart biventricular assist device in a failing single ventricle. J Thorac Cardiovasc Surg. 2006 Jun; 131(6):1407-8. View Abstract
139. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation. 2006 May 16; 113(19):2313-9. View Abstract
140. Prospective single-arm protocol of carvedilol in children with ventricular dysfunction. Pediatr Cardiol. 2006 May-Jun; 27(3):336-42. View Abstract
141. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet. 2006 Jan 21; 367(9506):233-9. View Abstract
142. International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant. 2004 Dec; 23(12):1313-33. View Abstract
143. The longitudinal impact of psychological functioning, medical severity, and family functioning in pediatric heart transplantation. J Heart Lung Transplant. 2004 Apr; 23(4):473-80. View Abstract
144. Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience. J Heart Lung Transplant. 2004 Feb; 23(2):178-85. View Abstract
145. Current status of heart transplantation in children: update 2003. Pediatr Clin North Am. 2003 Dec; 50(6):1375-91. View Abstract
146. Atrial tachyarrhythmias and permanent pacing after pediatric heart transplantation. J Heart Lung Transplant. 2003 Oct; 22(10):1126-33. View Abstract
147. Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A. Intensive Care Med. 2003 Jun; 29(6):985-988. View Abstract
148. Gastrointestinal complications after pediatric cardiac transplantation. J Heart Lung Transplant. 2002 Jul; 21(7):751-9. View Abstract
149. Arterial switch operation with a single coronary artery. J Thorac Cardiovasc Surg. 2002 Jun; 123(6):1164-72. View Abstract
150. Endothelial COX-2 induction by hypoxia liberates 6-keto-PGF1 alpha, a potent epithelial secretagogue. Adv Exp Med Biol. 2002; 507:107-12. View Abstract
151. Giant cell myocarditis in a 12-year-old girl with common variable immunodeficiency. Mayo Clin Proc. 2002 Jan; 77(1):92-6. View Abstract
152. Perioperative risk factors for development of protein-losing enteropathy following a Fontan procedure. Am J Cardiol. 2001 Nov 15; 88(10):1206-9. View Abstract
153. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr. 2001 Apr; 138(4):505-11. View Abstract
154. Clinical outcome of fenestrated Fontan patients after closure: the first 10 years. Circulation. 2000 Oct 24; 102(17):2094-9. View Abstract
155. Sialyl LewisX oligosaccharide preserves myocardial and endothelial function during cardioplegic ischemia. Ann Thorac Surg. 2000 Sep; 70(3):890-4. View Abstract
156. Long-term follow-up of pediatric cardiac patients requiring mechanical circulatory support. Ann Thorac Surg. 2000 Jan; 69(1):186-92. View Abstract
157. Left superior vena cava connection to unroofed coronary sinus associated with positional cyanosis: successful transcatheter treatment using Gianturco-Grifka vascular occlusion device. Catheter Cardiovasc Interv. 1999 Dec; 48(4):369-73. View Abstract
158. Sodium channel abnormalities are infrequent in patients with long QT syndrome: identification of two novel SCN5A mutations. Am J Med Genet. 1999 Oct 29; 86(5):470-6. View Abstract
159. Evolution of risk factors influencing early mortality of the arterial switch operation. J Am Coll Cardiol. 1999 May; 33(6):1702-9. View Abstract
160. Activated endothelial cells elicit paracrine induction of epithelial chloride secretion. 6-Keto-PGF1alpha is an epithelial secretagogue. J Clin Invest. 1998 Sep 15; 102(6):1161-72. View Abstract
161. Images in cardiovascular medicine. Anatomically corrected malposition of the great arteries [S,D,L]. Circulation. 1998 Mar 31; 97(12):1207. View Abstract
162. Long-term results of arterial switch repair of transposition of the great vessels. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 1998; 1:129-138. View Abstract
163. Soluble adhesion molecules in infants and children undergoing cardiopulmonary bypass. Circulation. 1997 Nov 04; 96(9 Suppl):II-352-7. View Abstract
164. A switch in time saves a statistical bind. JAMA. 1991 Dec 18; 266(23):3284-5. View Abstract
165. Amnesic patients give clues on structure of memory. JAMA. 1983 Oct 07; 250(13):1662-3. View Abstract
166. Palliation may block cure of incontinence in elderly. JAMA. 1983 Sep 16; 250(11):1371. View Abstract
167. Elderly patient needs assessment, not neglect. JAMA. 1983 Sep 02; 250(9):1132-3. View Abstract
168. Street drugs yield primate Parkinson's model. JAMA. 1983 Jul 01; 250(1):13-4. View Abstract
169. Premenstrual syndromes, depression linked. JAMA. 1983 Jun 03; 249(21):2864-6. View Abstract
170. Sound, shock waves shatter kidney stones. JAMA. 1983 May 13; 249(18):2434-5. View Abstract
171. Ambulatory dialysis: special boon for children. JAMA. 1983 May 06; 249(17):2290-1. View Abstract
172. 'Tricks' of trade aid kidney transplants. JAMA. 1983 May 06; 249(17):2288-90. View Abstract
173. Promising agents for limiting renal damage. JAMA. 1983 Apr 15; 249(15):1987. View Abstract
Show All Publications Show Fewer Publications